The story of Viagra, and its parent company copyright, presents a challenging case study for investors. Originally a blockbuster drug, generating billions in sales , its exclusivity period created a flood of knock-off medications, significantly impacting its market share . While certain firms may seek to capitalize on related treatments , the prese